We measured adenosine deaminase (ADA), lysozyme, fibronectin and carcinoembryonic antigen (CEA) in the pleural fluid of tuberculous and carcinomatous pleural effusion in order to discriminate these two groups. Tuberculous pleural effusion had significantly higher levels of ADAand lysozyme than did carcinomatous effusion. WhenADAactivity of more than 33 IU/7 is considered, diagnostic tests of tuberculous effusions showed a sensitivity of 100%, specificity of 95%and accuracy of 96%. A pleural fluid/serum ADAratio (pl-ADA/s-ADA) above 1.1 was found in 100% of tuberculous and in 53% of carcinomatous effusions (sensitivity 100%, specificity 47% , diagnostic accuracy 70%). A lysozyme level above 12^g/ml, selected as the discriminating limit, was found in 100% of tuberculous and in 17% of carcinomatous effusions (sensitivity 100% , specificity 83% , diagnostic accuracy 88%). Pleural fluid/serum lysozyme ratio (PL/SL) was also valuable in the discrimination of these two groups. Whenthe cut-off level of 1.2 was considered, diagnostic tests of tuberculous effusions showed a sensitivity of 100%, specificity of 88%and accuracy of 93%, respectively. The mean fibronectin concentration in pleural fluid with tuberculous effusion was significantly higher than that in carcinomatous effusion, but there was a marked overlap between these two groups. On the other hand, CEAwas significantly higher in carcinomatous effusions than in tuberculous effusions. At a cut-off level of 5 ng/ml, 53%of patients with carcinomatous effusion showed elevated pleural fluid CEAlevels, while none of the tuberculous effusion did (sensitivity 53% , specificity 100% , diagnostic accuracy 65%). The combined assay of ADA,lysozyme, pl-ADA/s-ADA, PL/SL and CEAprovide valuable information in the differentia] diagnosis between tuberculous and carcinomatous effusion, while fibronectin concentration can not be considered to have a definite diagnostic value.
culous and carcinomatous pleural effusion.
We measured adenosine deaminase (ADA), lysozyme and fibronectin, as well as carcinoembryonic antigen (CEA) in tuberculous and carcinomatous pleural effusions and evaluated the diagnostic value of these parameters in the differential diagnosis of these two groups.
MATERIALS AND METHODS
Fourteen patients with tuberculous pleural effusion and 37 patients with carcinomatous pleural effusion were included in the study. The diagnosis of tuberculous pleural effusion was established by means of positive culture results of pleural fluid or biopsy specimens (in two cases) and/or the existence of granulomas in the biopsied specimens (in twelve cases). The diagnosis of carcinomatous pleural effusion was based on a positive pleural biopsy and/or cytological results of the examination of pleural fluid. They included 23 bronchogenic carcinomas, 12 metastatic carcinomas (stomach, pancreas, gall bladder, liver, breast, uterus), one malignant lymphoma and one acute lymphocytic leukemia. Pleural fluid samples were collected in tubes containing sodium citrate as anticoagulant and centrifuged for 10 minutes at 3,000 rpm and were stored at -20°C until assayed. In some cases, serum (plasma) samples were obtained on the same day and processed as described above. ADAactivities were measured enzymatically using a commercial kit (AD test, Maruho, Osaka, Japan). Lysozyme level was measured by turbidimetric assay (2) . Fibronectin concentration was measured by enzyme-linked immunosorbent assay (MBL, Nagoya, Japan 2) Lysozyme level in pleural fluid and pleural fluid/serum lysozyme ratio
The lysozyme level in tuberculous pleural effusion (29.8 ± 9.7 jug/ml) was significantly (p< 0.001) higher than that in carcinomatous pleural effusion (9.0 ± 6.6^g/ml) (Fig. 2, left) . Lysozyme levels above 12 fig/ml, arbitrarily selected as the discriminating limit, were found in 100% of tuberculous and in 17%of carcinomatous (all metastatic) pleural effusions (sensitivity 100%, specificity 83 %, diagnostic accuracy 88%). Pleural fluid/serum lysozyme ratio (PL/SL) in tuberculous pleural effusion (2.7 ± 0.9) was significantly (p < 0.001) higher than that in car- diagnostic value of the parameters differentiating tuberculous from carcinomatous pleural effusion is summarized in Table 2 . All authors seemed to agree that ADA activity is not raised in carcinomatous effusion. Wealso confirmed that ADAin tuberculous pleural effusion was significantly higher than that in carcinomatous pleural effusion. However, two cases of carcinomatous pleural effusion (gastric cancer, uterine cancer) have ADAactivity above 33 IU// in our study. But this is not contradictory to previous reports because the specificity of ADA in the differential diagnosis of pleural effusion is not 100% (12, 13) . The value of pl-ADA/s-ADA ratio is also examined. Maritz et al. (9) indicated that a pl-ADA/s-ADAratio below 1.1 makes tuberculous pleural effusion highly unlikely. Pettersson et al. (1 1) reported that pl-ADA/s-ADAratios over 2.5 always denoted tuberculosis, empyemaor RAand there was no false positive or false negative responses. In the current study, a pl-ADA/s-ADA ratio over 2.0 always indicated tuberculous pleural effusion and below 1.1 highly suggested carcinomatous pleural effusion, although the specificity was not 100%.
ADAis abundant in lymphocytes, especially in T-lymphocytes, so lymphocytosis may be contributable to the elevation in pleural ADAactivity. We could not, however, find any correlation between lymphocyte number and ADAactivity in pleural fluid. Therefore, it may be assumed that in tuberculous pleural effusion, the origin of raised ADA activity is not in the absolute lymphocyte number but in the stimulated lymphocytes, although the exact reason why ADAis elevated only in tuberculous pleurisy among lymphocytic pleurisies is unclear.
Klockars et al. (4) Fibronectin concentration in pleural effusion has also been studied by several workers (17, 18 Klockars et al. (17) studied fibronectin concentration in various pleural fluids and suggested that increased fibronectin concentration reflects the presence of tuberculous or connective tissue disease rather than carcinomatous or infectious pleural effusion. In our study, the mean fibronectin concentration in tuberculous pleural effusion was significantly higher than that in carcinomatous pleural effusion. But there are considerable variations in fibronectin concentration and overlapping of tuberculous and carcinomatous pleural effusion. So the determination of fibronectin concentration of pleural effusion may not be reliably diagnostic in determining tuberculous pleural effusion.
The diagnostic value of CEAin pleural effusion has been studied extensively by many investigators (7, 13, (19) (20) (21) .
According to these reports, the CEA level in carcinomatous pleural effusion is significantly higher than that in non-carcinomatous pleural effusion. When the levels of significance is established as 10 -26 ng/ml, the specificity becomes 100%and the resulting degree of sensitivity ranged from 34-70%. Our results agree with those findings. But statistical analysis of CEAlevel between tuberculous and carcinomatous pleural fluid was performed using the nonparametric test because the distribution of CEAin carcinomatous pleural effusion did not meet the requirement of parametric tests.
In conclusion, pleural fluid ADA, lysozyme, pl-ADA/s-ADA, PL/SL and CEA provide useful information in the differential diagnosis of tuberculous and carcinomatous pleural effusion because of their high specificity, sensitivity and diagnostic accuracy, while fibronectin concentration can not be considered to have a reliable diagnostic value.
